News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: InternetForumUser post# 202764

Thursday, 01/15/2015 12:02:48 PM

Thursday, January 15, 2015 12:02:48 PM

Post# of 347009

Why would Peregrine want to keep delaying this trial; especially, if they know that CSM was responsible for the P2 Debacle?



Hint: If the courts need some legal documents on exactly what Peregrine should be reimbursed and if Peregrine signs a deal worth "$$$" then now this is a way to show the courts that Peregrine gets more money in the settlement.

Hmmm... if global leaders and scientific minds conclude PS Targeting is all the hype, then Peregrine gets everything they want out of the CSM damages and with the intent at stakes, CSM and insurance can both go under.

I doubt the insurance takes that risk.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y